具有新突变的婴儿银河状化症:早期呈现
Sonia Sharma1, Shailesh Gupta2, A P Mehta2
1Division of Pediatric Nephrology, Department Pediatric, Fortis Hospital, New Delhi, India.
Journal of pediatric genetics
|January 1, 2024
概括
Galactosialidosis (GS) 是一种罕见的 lysosomal 疾病. 基因检测发现了一种新的突变,有助于诊断新生儿的严重症状,如身体胀和呼吸困难.
科学领域:
- 遗传学 遗传学 是一个
- 生物化学 生物化学
- 儿科 儿科 儿科
背景情况:
- Galactosialidosis (GS) 是一种罕见的,遗传的溶酶体储存障碍.
- GS是由于 lysosomal酶β-galactosidase及其激活蛋白β-galactosidase的缺陷造成的.
- 早期诊断对于管理症状和潜在并发症至关重要.
研究的目的:
- 报告一个新生儿银河系化症病例.
- 突出诊断挑战和基因测试在识别新突变中的实用性.
主要方法:
- 一个新生儿出现严重症状的临床病例呈现.
- 对产前和产后临床发现的审查.
- 基因检测以确定潜在的突变.
主要成果:
- 患者出现了增加的身体胀,呼吸困难和出生时的.
- 临床发现包括粗的面部,肝炎,,血栓塞缩,脏范围蛋白尿和双边水.
- 基因分析发现了一种新的同卵性c.1158dupA突变,证实了Galactosialidosis的诊断.
结论:
- 这一案例强调了考虑罕见的遗传疾病的重要性,比如新生儿有复杂症状的Galactosialidosis.
- 对新突变的鉴定扩大了GS的已知遗传景观.
- 基因检测对于最终诊断和潜在的未来治疗策略至关重要.
关键词:
亚纳萨尔卡卡 (Anasarcaca) 是一个遗传性性综合征 (CNS) 是一种先天性性综合征.银河系化剂 (galactosialidosis) 是一种在新生儿中出现新生儿.血小板细胞减少症 (Thrombocytopenia) 是一种更多相关视频
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
8.6K
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
33.8K
相关概念视频
Glucose Transporters
22.8K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.8K
Inborn Errors of Metabolism
161
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
161
